Aspira Women’s Health Executes an Agreement with Axia Women’s Health to Launch Aspira Synergy Genetics Platform
Aspira Women’s Health Executes an Agreement with Axia Women’s Health to Launch Aspira Synergy Genetics Platform
Month: January 2022
Aspira Women’s Health Executes an Agreement with Axia Women’s Health to Launch Aspira Synergy Genetics Platform
Axia Women’s Health is one of the largest women’s health networks in the United States serving nearly half a million women a year…
Myriad Genetics Chief Scientific Officer Jerry Lanchbury Retires after 19 Years of Service
SALT LAKE CITY, Jan. 04, 2022 (GLOBE NEWSWIRE) — Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced the retirement of Jerry Lanchbury Ph.D.
Facility expansion begins on OLOL Primary Care for Women Clinic
BATON ROUGE, La. (BRPROUD) — Demolition has started in the expansion and renovation of the Primary Care for Women Clinic, Our Lady of the Lake Physician Group announced Tuesday. The clinic lo…
BayCare Names New President for Winter Haven and Winter Haven Women’s Hospitals
CLEARWATER, Fla., Jan. 4, 2022 /PRNewswire/ — BayCare Health System has named Kidada Hawkins as the next president of its Winter Haven and Winter Haven Women’s Hospitals, effective Feb. 21,
BayCare Names New President for Winter Haven and Winter Haven Women’s Hospitals
/PRNewswire/ — BayCare Health System has named Kidada Hawkins as the next president of its Winter Haven and Winter Haven Women’s Hospitals, effective Feb. 21,…
Middletown fire department union’s T-shirt sales help uninsured women get mammograms
One obstacle has been removed for women interested in getting their annual mammogram.
Gestalt Diagnostics and MindPeak provide the first Artificial Intelligence based diagnostics solution used in clinical routine pathology in the USA
/PRNewswire/ — Hamburg, Germany, based Mindpeak and Spokane, WA, based Gestalt Diagnostics have achieved a major success on their way to improve patient care…
Context Therapeutics® to Participate in Two January 2022 Investor Conferences
PHILADELPHIA, Jan. 04, 2022 (GLOBE NEWSWIRE) — Context Therapeutics Inc. (“Context” or the “Company”) (Nasdaq: CNTX), a women’s oncology company developing small molecule and immunotherapy treatments for breast and gynecological
Context Therapeutics® to Participate in Two January 2022 Investor Conferences
PHILADELPHIA, Jan. 04, 2022 (GLOBE NEWSWIRE) — Context Therapeutics Inc. (“Context” or the “Company”) (Nasdaq: CNTX), a women’s oncology company developing small molecule and immunotherapy treatments for breast and gynecological cancers, today announc…